These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17923585)

  • 1. Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension.
    Hackam DG; Spence JD; Garg AX; Textor SC
    Hypertension; 2007 Dec; 50(6):998-1003. PubMed ID: 17923585
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of atherosclerotic renal artery stenosis. Low dosage ACE inhibitors and angiotensin-receptor blockers are justified in certain cases].
    Alhadad A; Sterner G; Herlitz H
    Lakartidningen; 2009 Oct 28-Nov 3; 106(44):2836-8, 2840. PubMed ID: 19967962
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of angiotensin converting enzyme inhibition in renovascular hypertension.
    Burnier M; Waeber B; Nussberger J; Brunner HR
    J Hypertens Suppl; 1989 Sep; 7(7):S27-31. PubMed ID: 2693654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular disease.
    Deshmukh H; Barker E; Anbarasan T; Levin D; Bell S; Witham MD; George J
    Cardiovasc Ther; 2018 Dec; 36(6):e12474. PubMed ID: 30372589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute renal thrombosis induced by angiotensin-converting enzyme inhibitors in patients with renovascular hypertension.
    Hannedouche T; Godin M; Fries D; Fillastre JP
    Nephron; 1991; 57(2):230-1. PubMed ID: 2020353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal medical management in patients with renovascular hypertension.
    Balafa O; Kalaitzidis R; Siamopoulos KC
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):71-8. PubMed ID: 23494905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy of renovascular hypertension.
    Rosenthal T
    Drugs; 1993 Jun; 45(6):895-909. PubMed ID: 7691497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition in renal and hypertensive disorders.
    Götz R; Heidbreder E; Heidland A
    Clin Physiol Biochem; 1990; 8 Suppl 1():25-32. PubMed ID: 2257721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nuclear medicine in the study of renovascular hypertension].
    Rodríguez Fernández A; López Ruiz JM; Acosta Gómez MJ; Martínez del Valle MD; Llamas Elvira JM
    Rev Esp Med Nucl; 1999 Aug; 18(4):302-9. PubMed ID: 10610229
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term safety and efficacy of renin-angiotensin blockade in atherosclerotic renal artery stenosis.
    Sofroniadou S; Kassimatis T; Srirajaskanthan R; Reidy J; Goldsmith D
    Int Urol Nephrol; 2012 Oct; 44(5):1451-9. PubMed ID: 22127407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The consequences of renal artery stenosis.
    Rimmer JM
    Hosp Pract (Off Ed); 1994 Mar; 29(3):29-32, 35, 39-42. PubMed ID: 8132728
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bilateral renal artery stenosis--a cause of acute pulmonary edema].
    Høieggen A; Draganov B; Os I
    Tidsskr Nor Laegeforen; 2001 Jun; 121(15):1789-90. PubMed ID: 11464682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertension therapy in patients with renal artery stenosis].
    Vogt B; Maillard M; Burnier M
    Ther Umsch; 2012 May; 69(5):279-81. PubMed ID: 22547359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function in hypertension.
    Mimran A
    Am J Med; 1988 Jan; 84(1B):69-75. PubMed ID: 3277421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibition and renal insufficiency in patients with bilateral renovascular disease.
    Dominiczak A; Isles C; Gillen G; Brown JJ
    J Hum Hypertens; 1988 Jun; 2(1):53-6. PubMed ID: 3070034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiological role of tissue renin-angiotensin-aldosterone system (RAAS) in human atherosclerosis].
    Fukui K; Yamada H; Matsubara H
    Nihon Rinsho; 2012 Sep; 70(9):1556-61. PubMed ID: 23012803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options for renovascular hypertension.
    Spence JD
    Expert Opin Pharmacother; 2002 Apr; 3(4):411-6. PubMed ID: 11934344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular disease.
    Ritchie J; Green D; Alderson HV; Chrysochou C; Vassallo D; Sinha S; Kalra PA
    J Am Soc Hypertens; 2016 Feb; 10(2):149-158.e3. PubMed ID: 26778771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerotic renal artery stenosis: current status.
    Kwon SH; Lerman LO
    Adv Chronic Kidney Dis; 2015 May; 22(3):224-31. PubMed ID: 25908472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin system and cardiovascular risk.
    Schmieder RE; Hilgers KF; Schlaich MP; Schmidt BM
    Lancet; 2007 Apr; 369(9568):1208-19. PubMed ID: 17416265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.